Viewing Study NCT00980018


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2025-12-26 @ 4:08 AM
Study NCT ID: NCT00980018
Status: COMPLETED
Last Update Posted: 2021-07-01
First Post: 2009-09-16
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment
Sponsor: Novartis Pharmaceuticals
Organization: